| Name | Title | Contact Details |
|---|
Akimeka, LLC is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Kihei, HI. To find more information about Akimeka, LLC, please visit www.akimeka.com.
More than 20,000 genes make us human. Genes control critical aspects of health and disease — but what controls our genes? Foghorn® Therapeutics ($FHTX) is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order. By manipulating this system with our unique Gene Traffic Control™ platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease. With Gene Traffic Control™ Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.
Wolters Kluwer Clinical Drug Information connects you to the information and technology you need to strengthen medication decision making.
Healthcare Partners Investments is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Pharos Innovations is a Northfield, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.